Disclosure 0001493152-26-040736-1

SEC FORM 4

$27,580.00

Tonix Pharmaceuticals Holding Corp. (TNXP)

Purchase of 2,000 shares at $13.79 per share.

Reporting Person LEDERMAN SETH · Officer Title Chief Executive Officer · Transaction Code P

Traded Aug 27, 2026 · Disclosed Aug 31, 2026

Source: SEC Form 4 · 0001493152-26-040736 · filed 2026-08-31 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "Tonix Pharmaceuticals Holding Corp. (TNXP)." Disclosed 2026-08-31. https://desqlong.com/cards/0001493152-26-040736-1 (retrieved 2026-09-26).